| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.27 | 0.05 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.16 | 0.06 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.1 | 0.06 |